Results 21 to 30 of about 56,674 (254)
COVID-19 as a rare cause of facial nerve neuritis in a pediatric patient
Radiology Case Reports, 2021 COVID-19 has been noted to present with neurological symptoms in nearly 30% of patients. While children are more likely to be asymptomatic, neurological involvement has been observed.
Sultan Zain, BA, MPH +4 more
doaj +1 more source
Current diagnosis and treatment of vestibular neuritis: a narrative review [PDF]
Journal of Yeungnam Medical Science, 2022 Vertigo is the sensation of self-motion of the head or body when no self-motion is occurring or the sensation of distorted self-motion during an otherwise normal head movement.
Chang Hoon Bae +2 more
doaj +1 more source
Non-glaucomatous Optic Disc Cupping: A Brief Review [PDF]
Caspian Journal of Neurological Sciences, 2023 Although optic disc cupping is mostly seen in glaucoma patients, it can occur in non-glaucomatous optic neuropathies (NGON). The characteristics of NGON are cupping toxic optic neuropathies, optic neuritis, compressive ischemia, and hereditary nature ...
Hassan Behboudi, Ebrahim Azaripour
doaj
Isolated bitemporal hemianopia in a patient with COVID-19
Сеченовский вестник, 2020 Introduction. Symptoms of lesions of the I, VII and IX pairs of cranial nerves during SARS-CoV-2 infection are observed in about a third of cases. Isolated bitemporal hemianopia as a symptom of optic nerve damage at the chiasmal level in patients with ...
M. S. Zharkova +5 more
doaj +1 more source
Ueber „apoplectiforme Neuritis” [„Neuritis apoplectica”] [PDF]
Archiv für Psychiatrie und Nervenkrankheiten, 1905 n ...
openaire +1 more source
HSV-1 not only in human vestibular ganglia but also in the vestibular labyrinth [PDF]
, 2001 Reactivation of herpes simplex virus type 1 (HSV-1) in the vestibular ganglion (VG) is the suspected cause of vestibular neuritis (VN). Recent studies reported the presence of HSV-1 DNA not only in human VGs but also in vestibular nuclei, a finding that ...
Mascolo, Andrea +4 more
core +1 more source
Neuroprotection in a Novel Mouse Model of Multiple Sclerosis [PDF]
, 2013 Multiple sclerosis is an immune-mediated, demyelinating and neurodegenerative disease that currently lacks any neuroprotective treatments. Innovative neuroprotective trial designs are required to hasten the translational process of drug development.
Coffey, P +31 more
core +1 more source